CC
Income statement / Annual
Last year (2023), The Chemours Company's total revenue was $6.03 B,
a decrease of 11.29% from the previous year.
In 2023, The Chemours Company's net income was -$238.00 M.
See The Chemours Company’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
Operating Revenue |
$6.03 B
|
$6.79 B
|
$6.35 B
|
$4.97 B
|
$5.53 B
|
$6.64 B
|
$6.18 B
|
$5.40 B
|
$5.72 B
|
$6.43 B
|
Cost of Revenue |
$4.72 B |
$5.18 B |
$4.96 B |
$3.90 B |
$4.46 B |
$4.67 B |
$4.43 B |
$4.29 B |
$4.76 B |
$5.07 B |
Gross Profit |
$1.31 B |
$1.62 B |
$1.38 B |
$1.07 B |
$1.06 B |
$1.97 B |
$1.75 B |
$1.11 B |
$955.00 M |
$1.36 B |
Gross Profit Ratio |
0.22 |
0.24 |
0.22 |
0.21 |
0.19 |
0.3 |
0.28 |
0.21 |
0.17 |
0.21 |
Research and Development
Expenses |
$108.00 M
|
$118.00 M
|
$107.00 M
|
$93.00 M
|
$80.00 M
|
$82.00 M
|
$80.00 M
|
$80.00 M
|
$97.00 M
|
$143.00 M
|
General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$657.00 M
|
$602.00 M
|
$934.00 M
|
$632.00 M
|
$685.00 M
|
Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$1.29 B
|
$710.00 M
|
$592.00 M
|
$527.00 M
|
$548.00 M
|
$657.00 M
|
$602.00 M
|
$934.00 M
|
$632.00 M
|
$685.00 M
|
Other Expenses |
$0.00 |
$70.00 M |
$163.00 M |
$39.00 M |
-$293.00 M |
$162.00 M |
$79.00 M |
$247.00 M |
$44.00 M |
$45.00 M |
Operating Expenses |
$1.40 B |
$828.00 M |
$699.00 M |
$620.00 M |
$628.00 M |
$739.00 M |
$682.00 M |
$1.01 B |
$729.00 M |
$828.00 M |
Cost And Expenses |
$6.12 B |
$6.01 B |
$5.66 B |
$4.52 B |
$5.09 B |
$5.41 B |
$5.11 B |
$5.30 B |
$5.49 B |
$5.90 B |
Interest Income |
$0.00 |
$163.00 M |
$185.00 M |
$210.00 M |
$208.00 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$208.00 M |
$163.00 M |
$185.00 M |
$210.00 M |
$208.00 M |
$195.00 M |
$215.00 M |
$213.00 M |
$132.00 M |
$0.00 |
Depreciation &
Amortization |
$307.00 M
|
$291.00 M
|
$317.00 M
|
$320.00 M
|
$311.00 M
|
$284.00 M
|
$273.00 M
|
$284.00 M
|
$267.00 M
|
$257.00 M
|
EBITDA |
$197.00 M
|
$1.20 B
|
$1.21 B
|
$767.00 M
|
$482.00 M
|
$1.54 B
|
$1.35 B
|
$715.00 M
|
$211.00 M
|
$789.00 M
|
EBITDA Ratio |
0.03 |
0.18 |
0.19 |
0.17 |
0.09 |
0.26 |
0.24 |
0.12 |
0.1 |
0.13 |
Operating Income Ratio
|
-0.02
|
0.13
|
0.14
|
0.1
|
0.03
|
0.19
|
0.17
|
0.02
|
0.04
|
0.08
|
Total Other
Income/Expenses Net |
-$226.00 M
|
-$45.00 M
|
-$6.00 M
|
-$268.00 M
|
-$536.00 M
|
-$77.00 M
|
-$160.00 M
|
-$107.00 M
|
-$414.00 M
|
$18.00 M
|
Income Before Tax |
-$318.00 M |
$741.00 M |
$676.00 M |
$179.00 M |
-$124.00 M |
$1.16 B |
$912.00 M |
-$11.00 M |
-$188.00 M |
$550.00 M |
Income Before Tax Ratio
|
-0.05
|
0.11
|
0.11
|
0.04
|
-0.02
|
0.17
|
0.15
|
-0
|
-0.03
|
0.09
|
Income Tax Expense |
-$81.00 M |
$163.00 M |
$68.00 M |
-$40.00 M |
-$72.00 M |
$159.00 M |
$165.00 M |
-$18.00 M |
-$98.00 M |
$149.00 M |
Net Income |
-$238.00 M |
$578.00 M |
$608.00 M |
$219.00 M |
-$52.00 M |
$995.00 M |
$746.00 M |
$7.00 M |
-$90.00 M |
$400.00 M |
Net Income Ratio |
-0.04 |
0.09 |
0.1 |
0.04 |
-0.01 |
0.15 |
0.12 |
0 |
-0.02 |
0.06 |
EPS |
-1.6 |
3.72 |
3.69 |
1.33 |
-0.32 |
5.62 |
4.04 |
0.04 |
-0.5 |
2.21 |
EPS Diluted |
-1.6 |
3.65 |
3.6 |
1.32 |
-0.32 |
5.45 |
3.91 |
0.04 |
-0.5 |
2.19 |
Weighted Average Shares
Out |
$148.91 M
|
$155.36 M
|
$164.94 M
|
$164.68 M
|
$164.82 M
|
$176.97 M
|
$184.84 M
|
$181.62 M
|
$180.00 M
|
$181.37 M
|
Weighted Average Shares
Out Diluted |
$148.91 M
|
$158.30 M
|
$168.70 M
|
$166.35 M
|
$164.82 M
|
$182.57 M
|
$190.98 M
|
$183.42 M
|
$180.99 M
|
$182.76 M
|
Link |
|
|
|
|
|
|
|
|
|
|